Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L

Cell Death and Differentiation

Volumn 14, Issue 12, 2007, Pages 2021-2034

  Berg, D ^a   Lehne, M ^a   Muller N ^a   Siegmund, D ^a   Munkel S ^b   Sebald, W ^c   Pfizenmaier, K ^b   Wajant, H ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF STUTTGART   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; DEATH RECEPTOR; DEATH RECEPTOR 5; DISULFIDE; FAS ANTIGEN; HYBRID PROTEIN; TENASCIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; COVALENT BOND; CROSS LINKING; DISULFIDE BOND; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN INDUCTION; PROTEIN INTERACTION; RECEPTOR BINDING; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CROSS-LINKING REAGENTS; FAS LIGAND PROTEIN; HUMANS; JURKAT CELLS; MICE; MUTANT PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; TENASCIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

MURINAE;

EID: 36248942022     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402213     Document Type: Article

References (24)

1. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001; 104 487-501.
2. Bodmer JL, Schneider P, Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem Sci 2002; 27: 19-26.
3. Grell M, Douni E, Wajant H, Lohden M, Clause M, Maxeiner B et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995; 83: 793-802.
4. Schneider P, Hager N, Bodmer JL, Hahne M, Frei K, Fontana A et al. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptatic activity and loss of liver toxicity. J Exp Med 1998: 187: 1205-1213.
5. Wajant H, Moosmayer D, Wuest T, Bartke T, Gerlach E, Schonherr U et al. Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative. Oncogene 2001; 20: 4101-4106.
6. Haswell LE, Glennie MJ, Al-Shamkhani A. Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its figand, CD154. Eur J Immunol 2001; 31: 3094-3100.
7. Holler N, Tardivel A, Kovacsovics-Bankowski M, Hertig S. Gaide O, Martinon F et al. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol 2003; 23: 1428-1440.
8. Stone GW, Barzee S, Snarsky V, Kee K, Spina CA, Yu XF et al. Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines. J Virol 2006; 80: 1762-1772.
9. Mundle SD, Raze A. Defining the dynamics of self-assembled Fas-receptor activation. Trends Immunol 2002; 23: 187-194.
10. Siegel RM, Muppidi JR, Sarker M, Lobito A, Jen M, Martin D et al. SPOTS: Signaling protein oligomeric transduction structures are early mediators of death receptor-induced apoptosis at the plasma membrane. J Cell Biol 2004; 167: 735-744.
11. Hankler F, Behrle E, Dennehy KM, Wicovsky A, Peters N, Wamke C et al. The extracallular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability. J Cell Biol 2005; 168: 1087-1098.
12. Schneider P, Bodmer JL, Holler N, Mattmann C, Scuderi P, Tersikikh A et al. Characterization of Fas (Apo-1, C-D95)-Fas ligand interaction. J Biol Chem 1997; 272: 18827-18833.
13. Muhlenbeck F, Schneider P, Bodmer JL, Schwenzer R, Hauser A, Schubert G et al. The tumor necrosis factor-related apoptosis-inclucing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation. J Biol Chem 2000; 275: 32208-32213.
14. Kelley RF, Tolpal K, Lindstrom SH, Mathieu M, Billeci K, Derorge L et al. Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5-than DR4 to apoptosis signaling. J Biol Chem 2005; 260: 2205-2212.
15. Wu GS, Bums TF, Zhan Y, Alnemri ES, El-Deiry WS. Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Cancer Res 1999; 59: 2770-2775.
16. Schneider P, Olson D, Tardivel A, Browning B, Lugovskoy A, Gong D et al. Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Biol Chem 2003; 278: 5444-5454.
17. Suda T, Tanaka M, Miwa K, Negate S. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced reeftnice to Fas ligand. J Immunol 1996; 157: 3918.-3924.
18. Kammerer RA, Schulthess T, Landwehr R, Lustig A, Fischer D, Engel J. Tenascin-C hexabrachion assembly is a sequential two-step process initiated by coiled-coil alpha-helices. J Biol Chem 1998; 273 10602-10608.
19. Clancy L, Mruk K, Archer K, Woeffel M, Mongkolsapaya J, Screaton G et al. Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc Natl Acad Sci USA 2005; 102: 18099-18104.
20. Mérino D, Lalaoui N, Morizot A, Schneider P, Solary E, Micheau O. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. Mol Cell Biol 2006; 26: 7046-7055.
21. Schneider P, Thorne M, Burns K, Bodmer JL, Hofmann K, Kataoka T et al. TRAIL receptors 1 (DR41) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 1997; 7: 831-836.
22. Madams JP, de Jong J, van Hall T, Melief CJ, Offringa R. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J Exp Med 1999; 190: 1033-1038.
23. Siegmund D, Mass S, Zhou D, Baumann 8, Röder C, Kalthoff H et al. Role of caspases in CD95L- and TRAIL-induced non-apoptotic signalling in pancreatic tumour calls. Cell Signal 2007; 19: 1172-1184.
24. Shen BJ, Hage T, Sebald W. Global and local determinants for to kinetics of interleukin-4/interleukinn-4 receptor alpha chain interaction. A biosensor study employing recombinant interleukin-4-binding protein. Eur J Biochem 1996; 240: 252-261.